Display options
Cite
Bloy N, Pol J, Aranda F, et al. Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 2014;3(11):e963424doi: 10.4161/21624011.2014.963424.
Bloy, N., Pol, J., Aranda, F., Eggermont, A., Cremer, I., Fridman, W. H., Fučíková, J., Galon, J., Tartour, E., Spisek, R., Dhodapkar, M. V., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2014). Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology, 3(11), e963424. https://doi.org/10.4161/21624011.2014.963424
Bloy, Norma, et al. "Trial watch: Dendritic cell-based anticancer therapy." Oncoimmunology vol. 3,11 (2014): e963424. doi: https://doi.org/10.4161/21624011.2014.963424
Bloy N, Pol J, Aranda F, Eggermont A, Cremer I, Fridman WH, Fučíková J, Galon J, Tartour E, Spisek R, Dhodapkar MV, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 2014 Dec 21;3(11):e963424. doi: 10.4161/21624011.2014.963424. eCollection 2014 Nov. PMID: 25941593; PMCID: PMC4292311.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2014 Dec 21;3(11):e963424. doi: 10.4161/21624011.2014.963424. eCollection 2014 Nov.

Trial watch: Dendritic cell-based anticancer therapy.

Oncoimmunology

Norma Bloy, Jonathan Pol, Fernando Aranda, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fučíková, Jérôme Galon, Eric Tartour, Radek Spisek, Madhav V Dhodapkar, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi

Affiliations

  1. Gustave Roussy Cancer Campus ; Villejuif, France ; INSERM , U1138; Paris France ; Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers ; Paris France ; Université Paris-Sud/Paris XI ; Orsay, France.
  2. Gustave Roussy Cancer Campus ; Villejuif, France ; INSERM , U1138; Paris France ; Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers ; Paris France.
  3. Gustave Roussy Cancer Campus ; Villejuif, France.
  4. INSERM , U1138; Paris France ; Equipe 13; Centre de Recherche des Cordeliers ; Paris France ; Université Pierre et Marie Curie/Paris VI ; Paris France.
  5. Department of Immunology; 2nd Medical School Charles University and University Hospital Motol ; Prague, Czech Republic ; Sotio a.s. ; Prague, Czech Republic.
  6. INSERM , U1138; Paris France ; Université Pierre et Marie Curie/Paris VI ; Paris France ; Laboratory of Integrative Cancer Immunology; Centre de Recherche des Cordeliers ; Paris France ; Université Paris Descartes/Paris V; Sorbonne Paris Cité ; Paris France.
  7. Université Paris Descartes/Paris V; Sorbonne Paris Cité ; Paris France ; INSERM , U970; Paris France ; Pôle de Biologie; Hôpital Européen Georges Pompidou, AP-HP ; Paris France.
  8. Department of Medicine; Immunobiology and Yale Cancer Center; Yale University ; New Haven, CT USA.
  9. Gustave Roussy Cancer Campus ; Villejuif, France ; INSERM, U1015, CICBT507 ; Villejuif, France.
  10. INSERM , U1138; Paris France ; Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers ; Paris France ; Université Paris Descartes/Paris V; Sorbonne Paris Cité ; Paris France ; Pôle de Biologie; Hôpital Européen Georges Pompidou, AP-HP ; Paris France ; Metabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus ; Villejuif, France.
  11. Gustave Roussy Cancer Campus ; Villejuif, France ; INSERM , U1138; Paris France ; Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers ; Paris France ; Université Paris Descartes/Paris V; Sorbonne Paris Cité ; Paris France.

PMID: 25941593 PMCID: PMC4292311 DOI: 10.4161/21624011.2014.963424

Abstract

The use of patient-derived dendritic cells (DCs) as a means to elicit therapeutically relevant immune responses in cancer patients has been extensively investigated throughout the past decade. In this context, DCs are generally expanded, exposed to autologous tumor cell lysates or loaded with specific tumor-associated antigens (TAAs), and then reintroduced into patients, often in combination with one or more immunostimulatory agents. As an alternative, TAAs are targeted to DCs

Keywords: DC, dendritic cell; DC-based vaccination; FDA, Food and Drug Administration; IFN, interferon; MRC1, mannose receptor, C type 1; MUC1, mucin 1; TAA, tumor-associated antigen; TLR, Toll-like receptor; Toll-like receptor agonists; Treg, regulatory T cell; WT1, Wilms tumor 1; antigen cross-presentation; autophagy; iDC, immature DC; immunogenic cell death; mDC, mature DC; pDC, plasmacytoid DC; regulatory T cells

References

  1. Nat Med. 1999 Apr;5(4):405-11 - PubMed
  2. Science. 1999 Jun 11;284(5421):1835-7 - PubMed
  3. Clin Exp Immunol. 1999 Aug;117(2):244-51 - PubMed
  4. Cancer Res. 1999 Aug 15;59(16):4035-41 - PubMed
  5. J Cell Biol. 1999 Nov 1;147(3):599-610 - PubMed
  6. Cell Immunol. 1999 Dec 15;198(2):131-8 - PubMed
  7. J Immunother. 2000 Jan;23(1):59-66 - PubMed
  8. Cancer Res. 2000 Feb 15;60(4):1028-34 - PubMed
  9. J Gene Med. 1999 Nov-Dec;1(6):400-6 - PubMed
  10. J Exp Med. 2000 May 15;191(10):1699-708 - PubMed
  11. Nat Med. 2000 Sep;6(9):1011-7 - PubMed
  12. Cancer Lett. 2000 Oct 16;159(1):103-8 - PubMed
  13. J Immunol. 2000 Sep 15;165(6):3301-8 - PubMed
  14. Nat Immunol. 2000 Oct;1(4):305-10 - PubMed
  15. J Immunol. 2000 Oct 1;165(7):3797-803 - PubMed
  16. J Immunol. 2000 Nov 15;165(10):5713-9 - PubMed
  17. Nat Biotechnol. 2000 Dec;18(12):1273-8 - PubMed
  18. Nat Immunol. 2000 Dec;1(6):510-4 - PubMed
  19. J Exp Med. 2000 Dec 4;192(11):1535-44 - PubMed
  20. J Exp Med. 2000 Dec 18;192(12):F39-44 - PubMed
  21. J Neurosurg. 2001 Mar;94(3):474-81 - PubMed
  22. Cancer Res. 2001 Mar 15;61(6):2386-9 - PubMed
  23. Cancer. 2001 Jun 1;91(11):2136-47 - PubMed
  24. Science. 2001 Jul 13;293(5528):253-6 - PubMed
  25. Int J Cancer. 2001 Aug 15;93(4):539-48 - PubMed
  26. N Engl J Med. 2001 Aug 9;345(6):433-42 - PubMed
  27. Cell. 2001 Aug 10;106(3):271-4 - PubMed
  28. J Exp Med. 2001 Sep 17;194(6):769-79 - PubMed
  29. J Immunol. 2001 Oct 15;167(8):4693-700 - PubMed
  30. Cancer Res. 2001 Nov 1;61(21):7913-9 - PubMed
  31. Science. 2001 Nov 16;294(5546):1540-3 - PubMed
  32. Cell Immunol. 2001 Oct 10;213(1):4-13 - PubMed
  33. J Exp Med. 2002 Apr 1;195(7):953-8 - PubMed
  34. Anticancer Res. 2002 Mar-Apr;22(2A):613-21 - PubMed
  35. Cancer Gene Ther. 2002 Sep;9(9):787-97 - PubMed
  36. J Exp Ther Oncol. 2002 Nov-Dec;2(6):337-49 - PubMed
  37. J Exp Med. 2002 Dec 16;196(12):1627-38 - PubMed
  38. Int J Cancer. 2003 Mar 10;104(1):92-7 - PubMed
  39. Vaccine. 2003 Feb 14;21(9-10):883-90 - PubMed
  40. Annu Rev Immunol. 2003;21:685-711 - PubMed
  41. Cell Immunol. 2002 Nov;220(1):1-12 - PubMed
  42. Ann N Y Acad Sci. 2003 Apr;987:180-7 - PubMed
  43. Leukemia. 2003 May;17(5):894-9 - PubMed
  44. J Immunol. 2003 Jun 1;170(11):5391-7 - PubMed
  45. Oncol Rep. 2003 Sep-Oct;10(5):1237-40 - PubMed
  46. Immunity. 2003 Aug;19(2):225-34 - PubMed
  47. J Immunother. 2003 Sep-Oct;26(5):420-31 - PubMed
  48. Hepatogastroenterology. 2003 Sep-Oct;50(53):1281-4 - PubMed
  49. Br J Cancer. 2003 Nov 3;89(9):1736-42 - PubMed
  50. Chin Med J (Engl). 2003 Nov;116(11):1655-61 - PubMed
  51. Nat Rev Immunol. 2003 Dec;3(12):994-1003 - PubMed
  52. Cancer Res. 2003 Dec 15;63(24):8962-7 - PubMed
  53. Cell Immunol. 2003 Oct;225(2):65-74 - PubMed
  54. Am J Hematol. 2004 Mar;75(3):121-7 - PubMed
  55. World J Gastroenterol. 2004 Mar 1;10(5):630-3 - PubMed
  56. J Exp Med. 2004 Mar 15;199(6):815-24 - PubMed
  57. Clin Cancer Res. 2004 Apr 15;10(8):2891-901 - PubMed
  58. Nat Med. 2004 May;10(5):475-80 - PubMed
  59. Cancer Res. 2004 Jun 15;64(12):4357-65 - PubMed
  60. Science. 2004 Jul 9;305(5681):200-5 - PubMed
  61. J Immunol. 2004 Oct 1;173(7):4433-42 - PubMed
  62. Leukemia. 2004 Nov;18(11):1810-5 - PubMed
  63. Clin Cancer Res. 2004 Nov 15;10(22):7466-74 - PubMed
  64. J Immunol. 2005 Mar 1;174(5):3067-71 - PubMed
  65. Cancer Biol Ther. 2005 Mar;4(3):289-94 - PubMed
  66. N Engl J Med. 2005 Mar 10;352(10):987-96 - PubMed
  67. Nat Rev Immunol. 2005 Apr;5(4):296-306 - PubMed
  68. Clin Cancer Res. 2005 Apr 1;11(7):2576-82 - PubMed
  69. Blood. 2005 Aug 15;106(4):1278-85 - PubMed
  70. Anticancer Res. 2005 May-Jun;25(3A):1747-53 - PubMed
  71. Nat Rev Cancer. 2005 Aug;5(8):615-25 - PubMed
  72. Gene Ther. 2006 Jan;13(2):138-49 - PubMed
  73. J Cell Mol Med. 2005 Jul-Sep;9(3):643-54 - PubMed
  74. J Dermatol Sci. 2006 Apr;42(1):1-11 - PubMed
  75. J Cancer Res Clin Oncol. 2006 May;132(5):293-301 - PubMed
  76. Nat Med. 2006 Feb;12(2):214-9 - PubMed
  77. Eur J Immunol. 2006 May;36(5):1124-35 - PubMed
  78. Nat Rev Immunol. 2006 Jun;6(6):476-83 - PubMed
  79. Nat Rev Drug Discov. 2006 Jun;5(6):471-84 - PubMed
  80. Biochem Biophys Res Commun. 2006 Aug 4;346(3):829-39 - PubMed
  81. Cancer Res. 2006 Sep 1;66(17):8887-96 - PubMed
  82. Nat Rev Immunol. 2006 Oct;6(10):715-27 - PubMed
  83. Science. 2007 Jan 5;315(5808):107-11 - PubMed
  84. J Surg Oncol. 2007 Feb 1;95(2):123-8 - PubMed
  85. Cancer Immunol Immunother. 2007 Sep;56(9):1459-69 - PubMed
  86. Nat Rev Immunol. 2007 Mar;7(3):179-90 - PubMed
  87. Anticancer Res. 2007 Mar-Apr;27(2):1137-41 - PubMed
  88. J Clin Invest. 2007 May;117(5):1195-203 - PubMed
  89. Vaccine. 2007 Jun 15;25(25):4757-66 - PubMed
  90. J Immunol. 2007 Sep 1;179(5):3371-9 - PubMed
  91. Immunol Rev. 2007 Oct;219:118-42 - PubMed
  92. Nat Rev Immunol. 2007 Oct;7(10):790-802 - PubMed
  93. Cancer Res. 2007 Sep 15;67(18):8847-55 - PubMed
  94. J Immunother. 2007 Oct;30(7):705-14 - PubMed
  95. J Immunother. 2007 Oct;30(7):715-26 - PubMed
  96. Nature. 2007 Sep 27;449(7161):419-26 - PubMed
  97. Immunol Rev. 2007 Dec;220:129-50 - PubMed
  98. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6666-72 - PubMed
  99. J Immunother. 2008 Jan;31(1):101-12 - PubMed
  100. Nat Biotechnol. 2008 Mar;26(3):326-34 - PubMed
  101. Nat Rev Cancer. 2008 Apr;8(4):299-308 - PubMed
  102. J Clin Oncol. 2008 Jul 1;26(19):3235-41 - PubMed
  103. Immunity. 2008 Sep 19;29(3):497-510 - PubMed
  104. J Clin Oncol. 2008 Sep 20;26(27):4410-7 - PubMed
  105. Oncogene. 2008 Oct 6;27(45):5920-31 - PubMed
  106. Nat Rev Cancer. 2009 Mar;9(3):167-81 - PubMed
  107. J Immunol. 2009 Jun 1;182(11):6815-23 - PubMed
  108. Cancer Immunol Immunother. 2010 Mar;59(3):389-95 - PubMed
  109. Vaccine. 2009 Nov 23;27(50):7116-24 - PubMed
  110. Drug News Perspect. 2009 Oct;22(8):445-51 - PubMed
  111. J Transl Med. 2010 Jan 15;8:4 - PubMed
  112. Cancer Res. 2010 Feb 15;70(4):1281-5 - PubMed
  113. Immunol Rev. 2010 Mar;234(1):18-31 - PubMed
  114. Immunol Rev. 2010 Mar;234(1):199-212 - PubMed
  115. J Immunol. 2010 Jun 1;184(11):6151-60 - PubMed
  116. J Exp Med. 2010 Jun 7;207(6):1273-81 - PubMed
  117. J Exp Med. 2010 Jun 7;207(6):1247-60 - PubMed
  118. J Exp Med. 2010 Jun 7;207(6):1261-71 - PubMed
  119. J Exp Med. 2010 Jun 7;207(6):1283-92 - PubMed
  120. Blood. 2010 Sep 9;116(10):1685-97 - PubMed
  121. Nat Rev Drug Discov. 2010 Jul;9(7):513-4 - PubMed
  122. Immunotherapy. 2010 Mar;2(2):137-40 - PubMed
  123. Nat Med. 2010 Aug;16(8):858-9 - PubMed
  124. Nat Biotechnol. 2010 Aug;28(8):813-5 - PubMed
  125. N Engl J Med. 2010 Jul 29;363(5):411-22 - PubMed
  126. Cancer Immunol Immunother. 2011 Feb;60(2):227-34 - PubMed
  127. J Neurooncol. 2011 Jul;103(3):699-704 - PubMed
  128. PLoS One. 2010 Dec 20;5(12):e15605 - PubMed
  129. Cancer Metastasis Rev. 2011 Mar;30(1):13-25 - PubMed
  130. Cytotherapy. 2011 Aug;13(7):774-85 - PubMed
  131. Histopathology. 2011 Feb;58(3):481-3 - PubMed
  132. Science. 2011 Mar 25;331(6024):1565-70 - PubMed
  133. Clin Cancer Res. 2011 Jun 1;17(11):3520-6 - PubMed
  134. N Engl J Med. 2011 Jul 14;365(2):127-38 - PubMed
  135. Cancer Res. 2011 Jul 15;71(14):4821-33 - PubMed
  136. J Cancer. 2011;2:363-8 - PubMed
  137. Cancer Res. 2011 Sep 1;71(17):5827-37 - PubMed
  138. Cell Death Differ. 2012 Jan;19(1):107-20 - PubMed
  139. Nat Rev Drug Discov. 2011 Aug 01;10(8):591-600 - PubMed
  140. Blood. 2011 Oct 13;118(15):4111-9 - PubMed
  141. Science. 2011 Aug 26;333(6046):1109-12 - PubMed
  142. Cancer. 2012 May 1;118(9):2476-85 - PubMed
  143. Blood. 2011 Dec 22;118(26):6836-44 - PubMed
  144. J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):465-75 - PubMed
  145. Nature. 2011 Oct 26;478(7370):460 - PubMed
  146. Science. 2011 Oct 28;334(6055):466 - PubMed
  147. Annu Rev Immunol. 2012;30:1-22 - PubMed
  148. Science. 2011 Dec 16;334(6062):1573-7 - PubMed
  149. J Transl Med. 2011 Dec 30;9:223 - PubMed
  150. J Exp Med. 2012 Jan 16;209(1):109-21 - PubMed
  151. Blood. 2012 Mar 8;119(10):2284-92 - PubMed
  152. J Clin Invest. 2012 Feb;122(2):575-85 - PubMed
  153. Cell. 2011 Dec 9;147(6):1216-7 - PubMed
  154. Nat Rev Cancer. 2012 Jan 24;12(2):83 - PubMed
  155. Nat Rev Drug Discov. 2012 Feb 03;11(3):215-33 - PubMed
  156. J Exp Med. 2012 Mar 12;209(3):495-506 - PubMed
  157. Biomaterials. 2012 Jun;33(16):4229-39 - PubMed
  158. Cancer Lett. 2013 May 28;332(2):225-8 - PubMed
  159. Nat Rev Cancer. 2012 Mar 22;12(4):265-77 - PubMed
  160. N Engl J Med. 2012 May 24;366(21):2008-16 - PubMed
  161. Eur J Immunol. 2012 Aug;42(8):1989-98 - PubMed
  162. Nat Rev Urol. 2012 Jun 19;9(7):386-96 - PubMed
  163. Oncoimmunology. 2012 Mar 1;1(2):227-228 - PubMed
  164. Oncoimmunology. 2012 Mar 1;1(2):240-241 - PubMed
  165. Oncoimmunology. 2012 Mar 1;1(2):252-254 - PubMed
  166. Oncoimmunology. 2012 May 1;1(3):287-357 - PubMed
  167. Oncoimmunology. 2012 May 1;1(3):306-315 - PubMed
  168. Oncoimmunology. 2012 May 1;1(3):380-382 - PubMed
  169. Nat Rev Immunol. 2012 Jul 13;12(8):557-69 - PubMed
  170. Int J Clin Oncol. 2013 Aug;18(4):657-65 - PubMed
  171. N Engl J Med. 2012 Sep 27;367(13):1187-97 - PubMed
  172. Oncol Rep. 2012 Oct;28(4):1301-8 - PubMed
  173. Oncoimmunology. 2012 Aug 1;1(5):699-716 - PubMed
  174. Oncoimmunology. 2012 Aug 1;1(5):762-764 - PubMed
  175. N Engl J Med. 2012 Sep 27;367(13):1256-7 - PubMed
  176. Science. 2012 Sep 28;337(6102):1678-84 - PubMed
  177. Immunotherapy. 2012 Sep;4(9):867-9 - PubMed
  178. Annu Rev Immunol. 2013;31:51-72 - PubMed
  179. Nat Immunol. 2012 Dec;13(12):1145-54 - PubMed
  180. Oncoimmunology. 2012 Sep 1;1(6):847-855 - PubMed
  181. Oncoimmunology. 2012 Oct 1;1(7):1074-1083 - PubMed
  182. Oncoimmunology. 2012 Oct 1;1(7):1111-1134 - PubMed
  183. Oncoimmunology. 2012 Oct 1;1(7):1194-1196 - PubMed
  184. Oncoimmunology. 2012 Oct 1;1(7):1218-1219 - PubMed
  185. Nat Rev Mol Cell Biol. 2012 Dec;13(12):780-8 - PubMed
  186. Oncoimmunology. 2012 Nov 1;1(8):1323-1343 - PubMed
  187. Oncoimmunology. 2012 Nov 1;1(8):1398-1400 - PubMed
  188. Oncoimmunology. 2012 Nov 1;1(8):1451-1453 - PubMed
  189. Oncoimmunology. 2012 Dec 1;1(9):1661-1663 - PubMed
  190. Methods Mol Biol. 2013;969:111-25 - PubMed
  191. J Clin Invest. 2013 Feb;123(2):844-54 - PubMed
  192. Vaccine. 2013 Feb 6;31(8):1141-56 - PubMed
  193. Annu Rev Immunol. 2013;31:743-91 - PubMed
  194. Curr Oncol Rep. 2013 Apr;15(2):65-8 - PubMed
  195. Clin Transl Oncol. 2013 Oct;15(10):780-8 - PubMed
  196. Curr Opin Rheumatol. 2013 Mar;25(2):268-74 - PubMed
  197. J Immunother. 2013 Feb;36(2):152-7 - PubMed
  198. N Engl J Med. 2013 Feb 7;368(6):551-60 - PubMed
  199. Sci Transl Med. 2013 Feb 13;5(172):172ra20 - PubMed
  200. Oncoimmunology. 2013 Jan 1;2(1):e22664 - PubMed
  201. Oncoimmunology. 2013 Jan 1;2(1):e22338 - PubMed
  202. Oncoimmunology. 2013 Jan 1;2(1):e23033 - PubMed
  203. Expert Opin Ther Targets. 2013 May;17(5):481-3 - PubMed
  204. Biomed Res Int. 2013;2013:976383 - PubMed
  205. Annu Rev Immunol. 2013;31:563-604 - PubMed
  206. Oncoimmunology. 2013 Feb 1;2(2):e23040 - PubMed
  207. Oncoimmunology. 2013 Feb 1;2(2):e23079 - PubMed
  208. Oncoimmunology. 2013 Feb 1;2(2):e23080 - PubMed
  209. Oncoimmunology. 2013 Feb 1;2(2):e23335 - PubMed
  210. J Transl Med. 2013 Mar 28;11:83 - PubMed
  211. Immunity. 2013 Apr 18;38(4):818-30 - PubMed
  212. Immunity. 2013 Apr 18;38(4):729-41 - PubMed
  213. Ann N Y Acad Sci. 2013 May;1284:24-30 - PubMed
  214. Oncoimmunology. 2013 Mar 1;2(3):e23083 - PubMed
  215. J Transl Med. 2013 May 31;11:135 - PubMed
  216. Curr Opin Immunol. 2013 Jun;25(3):396-402 - PubMed
  217. Cancer Immunol Immunother. 2013 Aug;62(8):1381-92 - PubMed
  218. Oncoimmunology. 2013 Apr 1;2(4):e24117 - PubMed
  219. Acta Med Iran. 2013 May 30;51(5):284-8 - PubMed
  220. Oncoimmunology. 2013 May 1;2(5):e23887 - PubMed
  221. Oncoimmunology. 2013 May 1;2(5):e24238 - PubMed
  222. Oncoimmunology. 2013 May 1;2(5):e24437 - PubMed
  223. Immunol Rev. 2013 Jul;254(1):170-89 - PubMed
  224. J Transl Med. 2013 Jun 20;11:152 - PubMed
  225. Oncoimmunology. 2013 Mar 1;2(3):e23186 - PubMed
  226. Oncoimmunology. 2013 Mar 1;2(3):e23429 - PubMed
  227. Oncoimmunology. 2013 Mar 1;2(3):e23431 - PubMed
  228. Cancer Immunol Immunother. 2013 Sep;62(9):1499-509 - PubMed
  229. Genes Dev. 2013 Jul 1;27(13):1447-61 - PubMed
  230. Ann Surg Oncol. 2013 Oct;20(10):3233-9 - PubMed
  231. J Clin Invest. 2013 Aug;123(8):3383-94 - PubMed
  232. J Gastrointest Surg. 2013 Sep;17(9):1609-17 - PubMed
  233. Nat Rev Cancer. 2013 Aug;13(8):525-41 - PubMed
  234. Immunity. 2013 Jul 25;39(1):74-88 - PubMed
  235. Oncoimmunology. 2013 Jun 1;2(6):e24568 - PubMed
  236. Oncoimmunology. 2013 Jun 1;2(6):e24677 - PubMed
  237. Ann Oncol. 2013 Oct;24(10):2686-93 - PubMed
  238. J Clin Invest. 2013 Jul;123(7):3135-45 - PubMed
  239. Vaccine. 2013 Oct 1;31(42):4802-11 - PubMed
  240. Cell. 2013 Aug 15;154(4):843-58 - PubMed
  241. Hum Vaccin Immunother. 2012 Dec 1;8(12):1742 - PubMed
  242. Future Oncol. 2013 Sep;9(9):1271-81 - PubMed
  243. Br J Cancer. 2013 Sep 17;109(6):1488-97 - PubMed
  244. J Exp Med. 2013 Sep 23;210(10):1961-76 - PubMed
  245. Tumour Biol. 2014 Feb;35(2):987-94 - PubMed
  246. Anticancer Res. 2013 Sep;33(9):3855-9 - PubMed
  247. Cell Death Differ. 2014 Jan;21(1):92-9 - PubMed
  248. Oncoimmunology. 2013 Jul 1;2(7):e24850 - PubMed
  249. Oncoimmunology. 2013 Jul 1;2(7):e24963 - PubMed
  250. J Cancer Res Clin Oncol. 2013 Dec;139(12):2097-110 - PubMed
  251. Oncol Lett. 2013 Aug;6(2):537-541 - PubMed
  252. PLoS One. 2013 Oct 11;8(10):e77159 - PubMed
  253. Cancer Chemother Pharmacol. 2014 Jan;73(1):1-8 - PubMed
  254. Pathol Oncol Res. 2014 Apr;20(2):357-65 - PubMed
  255. Immunotherapy. 2013 Nov;5(11):1177-82 - PubMed
  256. Cancers (Basel). 2013 May 06;5(2):511-8 - PubMed
  257. J Drug Deliv. 2013;2013:869718 - PubMed
  258. Oncoimmunology. 2013 Oct 1;2(10):e25771 - PubMed
  259. Immunity. 2013 Dec 12;39(6):1095-107 - PubMed
  260. Nature. 2013 Dec 12;504(7479):296-300 - PubMed
  261. Immunity. 2013 Dec 12;39(6):1070-81 - PubMed
  262. Oncoimmunology. 2013 Sep 1;2(9):e25595 - PubMed
  263. Anticancer Res. 2013 Dec;33(12):5495-500 - PubMed
  264. Oncoimmunology. 2013 Oct 1;2(10):e26381 - PubMed
  265. Oncoimmunology. 2013 Oct 1;2(10):e26260 - PubMed
  266. Gan To Kagaku Ryoho. 2013 Nov;40(12):1596-9 - PubMed
  267. Oncoimmunology. 2013 Oct 1;2(10):e25997 - PubMed
  268. Oncoimmunology. 2013 Oct 1;2(10):e26527 - PubMed
  269. Immunity. 2014 Jan 16;40(1):105-16 - PubMed
  270. Hum Vaccin Immunother. 2014;10(4):970-6 - PubMed
  271. Cytotherapy. 2014 Feb;16(2):234-44 - PubMed
  272. Nat Commun. 2014;5:3056 - PubMed
  273. Oncoimmunology. 2013 Nov 1;2(11):e27010 - PubMed
  274. Oncoimmunology. 2013 Dec 1;2(12):e26621 - PubMed
  275. Oncoimmunology. 2013 Dec 1;2(12):e27158 - PubMed
  276. N Engl J Med. 2014 Feb 20;370(8):709-22 - PubMed
  277. Clin Cancer Res. 2014 May 1;20(9):2433-44 - PubMed
  278. Oncoimmunology. 2014 Jan 1;3(1):e27048 - PubMed
  279. Oncoimmunology. 2014 Jan 1;3(1):e27296 - PubMed
  280. Clin Cancer Res. 2014 May 1;20(9):2457-65 - PubMed
  281. Mol Clin Oncol. 2013 Jul;1(4):649-654 - PubMed
  282. PLoS One. 2014 Apr 03;9(4):e93886 - PubMed
  283. Oncoimmunology. 2014 Jan 1;3(1):e27297 - PubMed
  284. Oncoimmunology. 2014 Jan 1;3(1):e27400 - PubMed
  285. BMC Cancer. 2014 Apr 10;14:251 - PubMed
  286. Oncoimmunology. 2014 Jan 1;3(1):e27589 - PubMed
  287. Sci Transl Med. 2014 Apr 16;6(232):232ra51 - PubMed
  288. Cancer Immunol Immunother. 2014 Aug;63(8):797-806 - PubMed
  289. Oncoimmunology. 2014 Jan 1;3(1):e28186 - PubMed
  290. Cytotherapy. 2014 Jul;16(7):934-45 - PubMed
  291. Oncoimmunology. 2014 Jan 1;3(1):e27622 - PubMed
  292. J Immunother Cancer. 2014 Feb 18;2:4 - PubMed
  293. J Immunol. 2014 Jun 15;192(12):5776-88 - PubMed
  294. Immunity. 2014 May 15;40(5):642-56 - PubMed
  295. J Exp Med. 2014 Jun 2;211(6):1153-66 - PubMed
  296. Lancet Oncol. 2014 Jun;15(7):e257-67 - PubMed
  297. Ir J Med Sci. 2015 Jun;184(2):457-61 - PubMed
  298. J Immunother Cancer. 2014 May 13;2:10 - PubMed
  299. Cancer Immunol Res. 2014 Aug;2(8):741-55 - PubMed
  300. J Transl Med. 2014 Jun 19;12:175 - PubMed
  301. Cell Mol Immunol. 2015 Jan;12(1):87-95 - PubMed
  302. Cancer Immunol Immunother. 2014 Oct;63(10):1061-71 - PubMed
  303. Oncoimmunology. 2014 May 01;3:e28344 - PubMed
  304. J Transl Med. 2014 Jul 22;12:209 - PubMed
  305. Clin Cancer Res. 2014 Aug 15;20(16):4228-39 - PubMed
  306. Nat Rev Immunol. 2014 Aug;14(8):546-58 - PubMed
  307. Asian Pac J Cancer Prev. 2014;15(14):5909-16 - PubMed
  308. Oncoimmunology. 2014 May 14;3:e28780 - PubMed
  309. Oncoimmunology. 2014 Jun 03;3:e29030 - PubMed
  310. Oncoimmunology. 2014 Aug 01;3:e29179 - PubMed
  311. Oncoimmunology. 2014 Apr 29;3:e28610 - PubMed
  312. Am J Hematol. 2014 Dec;89(12):1092-6 - PubMed
  313. Cell Death Differ. 2015 Jan;22(1):58-73 - PubMed
  314. Oncoimmunology. 2014 Aug 03;3(8):e954832 - PubMed
  315. Oncoimmunology. 2014 Dec 13;3(9):e954929 - PubMed
  316. Oncoimmunology. 2013 Aug 7;2(8):e26084 - PubMed
  317. J Exp Med. 1973 May 1;137(5):1142-62 - PubMed
  318. Nat Med. 1995 Dec;1(12):1297-302 - PubMed
  319. Tohoku J Exp Med. 1993 Mar;169(3):187-95 - PubMed
  320. J Surg Oncol. 1993 Apr;52(4):207-12 - PubMed
  321. J Exp Med. 1996 Jan 1;183(1):317-22 - PubMed
  322. J Exp Med. 1996 Jan 1;183(1):87-97 - PubMed
  323. J Immunother Emphasis Tumor Immunol. 1995 Aug;18(2):86-94 - PubMed
  324. J Exp Med. 1996 Apr 1;183(4):1357-65 - PubMed
  325. J Exp Med. 1996 Aug 1;184(2):465-72 - PubMed
  326. J Leukoc Biol. 1997 Feb;61(2):125-32 - PubMed
  327. Stem Cells. 1997;15(2):94-103 - PubMed
  328. Int J Cancer. 1997 Mar 17;70(6):706-15 - PubMed
  329. Hum Gene Ther. 1997 Jul 20;8(11):1355-63 - PubMed
  330. J Exp Med. 1997 Oct 6;186(7):1177-82 - PubMed
  331. J Exp Med. 1997 Oct 20;186(8):1247-56 - PubMed
  332. Eur J Immunol. 1997 Oct;27(10):2702-7 - PubMed
  333. Oncology. 1998 Jan-Feb;55(1):65-9 - PubMed
  334. J Immunother. 1998 Jan;21(1):41-7 - PubMed
  335. Nature. 1998 Mar 5;392(6671):86-9 - PubMed
  336. Nature. 1998 Mar 19;392(6673):245-52 - PubMed
  337. J Immunol. 1998 Apr 1;160(7):3081-5 - PubMed
  338. Cancer. 1998 Apr 15;82(8):1468-75 - PubMed
  339. Nat Med. 1998 May;4(5):594-600 - PubMed
  340. J Surg Oncol. 1998 Jun;68(2):79-91 - PubMed
  341. Cell Immunol. 1998 Apr 10;185(1):65-74 - PubMed
  342. Oncol Rep. 1998 Sep-Oct;5(5):1185-9 - PubMed
  343. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9482-7 - PubMed
  344. J Immunol. 1998 Sep 1;161(5):2094-8 - PubMed
  345. J Exp Med. 1998 Oct 5;188(7):1359-68 - PubMed
  346. J Immunol. 1998 Nov 15;161(10):5516-24 - PubMed
  347. J Exp Med. 1999 Feb 1;189(3):587-92 - PubMed
  348. Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1036-41 - PubMed

Publication Types